ArticleBriefings in bioinformatics2025
AttenRNA: multi-scale deep attentive model with RNA feature variability analysis.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Accurate identification of diverse RNA types, including messenger RNAs (mRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), is essential for understanding their roles in gene regulation, disease progression, and epigenetic modification. Existing studies have primarily focused on binary classification tasks, such as distinguishing lncRNAs from mRNAs or identifying specific circRNAs, often overlooking the complex sequence patterns shared across multiple RNA types. To address this limitation, we developed AttenRNA, a multi-class classification model that integrates multi-scale k-mer embeddings and attention mechanisms to simultaneously differentiate between various RNA classes. AttenRNA achieved high weighted F1 scores of 89.8% and 89.6% on the validation and test sets, respectively, demonstrating strong classification performance and robustness. Dimensionality reduction using Uniform Manifold Approximation and Projection further confirmed the model's ability to learn discriminative features among RNA types. Additionally, AttenRNA exhibited strong generalization ability on cross-species data, achieving weighted F1 scores of 83.89% and 83.38% on the mouse RNA validation and test sets, respectively. These results suggest that AttenRNA offers a reliable and scalable solution for systematic RNA function analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.